NANOCOVAX is the Covid-19 vaccine candidate researched and developed by Nanogen based on recombinant DNA/protein technology. After having accomplished the pre-clinical trial with high safety and efficacy, Nano Covax is the first Covid-19 vaccine to be approved by Vietnam’s Ministry of Health to conduct clinical trial in Vietnam. Phase 1 of the clinical trial started on December 2020.
Neutralizing antibody bind to Sars-CoV-2
Box of 1 prefilled syringe x 1 mL
A clear, colorless injectable solution containing a mixture of recombinant monoclonal antibodies targeting the nCoV-2019 protein. It is pre-filled in a glass syringe with an attached needle and a plastic plunger.
